Risk assessment on the spread of carbapenemase-producing Enterobacteriaceae (CPE) through patient transfer between healthcare facilities, with special emphasis on cross-border transfer
The purpose of this risk assessment is to evaluate the risk to the citizens of Europe of CPE spread through patient mobility and to assess the effectiveness of infection control methods to stop the spread of CPE within healthcare institutions.
Communicable disease threats report, Week 20, 10-16 May 2015
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 10-16 May 2015, and includes updates on influenza, Salmonella Enteritidis, polio, avian influenza, Ebola virus, Mycobacterium chimaera and MERS.
- Antimicrobial resistance
- Antimicrobial Resistance and Healthcare-associated Infections Programme
- Ebola haemorrhagic fever
- Emerging and Vector-borne Diseases Programme
- Healthcare-associated infections
- Influenza in humans, seasonal
- Middle East respiratory syndrome coronavirus
- Mycobacterium chimaera
- Public health threat
- Vaccine Preventable Diseases Programme
- Western Africa
Communicable disease threats report, 17-23 May 2015, week 21
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 17-23 May 2015, and includes updates on Salmonella Enteritidis, influenza, Mycobacterium chimaera, Ebola virus, MERS, avian influenza and polio.
RRA: Invasive cardiovascular infection by Mycobacterium chimaera associated with the 3T heater-cooler system used during open-heart surgery - 1st update, 21 November 2016
In view of new evidence, ECDC has updated its rapid risk assessment on the potential risk of invasive cardiovascular infection by M. chimaera associated with the use of heater-cooler units.
Rapid risk assessment: Carbapenem-resistant Acinetobacter baumannii in healthcare settings – 8 December 2016
This risk assessment provides an overview of the epidemiological situation in Europe and describes a number of response options.
Candida auris in healthcare settings
Due to its propensity to cause outbreaks and its antifungal resistance, C. auris poses a risk for patients in healthcare facilities in Europe. Difficulties with laboratory identification, combined with a lack of awareness of this new Candida species, might result in unnoticed outbreaks. There is a clear need to raise awareness in European healthcare facilities in order adapt laboratory testing strategies and implement enhanced control measures to prevent further hospital outbreaks.
Healthcare-associated infections pose a major public health threat in long-term care facilities in Europe
An EU-wide survey estimated that 4.2 million healthcare-associated infections occur every year in European long-term care facilities, compared to an estimated 3.5 million occurring in European acute care hospitals, and that on any given day, over 116 400 residents have at least one active healthcare-associated infection. Pete Kinross, an expert in surveillance of healthcare-associated infections at the European Centre for Disease Prevention and Control (ECDC), speaks about these findings during a session on antimicrobial resistance in these healthcare settings, at ECCMID 2017.
Rapid risk assessment: Candida auris in healthcare settings – Europe
This rapid risk assessment update appraises the risk for spread of C. auris in hospitals in the European Union and European Economic Area (EU/EEA) countries
Rapid risk assessment: Hospital-acquired malaria infections in the European Union
Following the occurrence of several hospital-acquired malaria cases in the European Union (EU), ECDC has assessed the risk related to transmission of the parasite in hospital settings.
Rapid risk assessment: Carbapenem-resistant Enterobacteriaceae - first update
This update of the 2016 ECDC Rapid Risk Assessment on carbapenem-resistant Enterobacteriaceae (CRE) evaluates the risk for patients and healthcare systems in EU/EEA countries due to the global spread of CRE.